Hot Features
Premium
Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 747,431 |
|
|||||
| News | - | ||||||
| Day High | 30.28 | Low High |
|||||
| Day Low | 28.71 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Agios Pharmaceuticals Inc | AGIO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.10 | 0.34% | 29.53 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 29.27 | 28.71 | 30.28 | 29.53 | 29.43 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,381 | 747,431 | US$ 29.71 | US$ 22,209,663 | - | 19.795 - 35.48 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:29:19 | 4 | US$ 29.54 | USD |
Agios Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.66B | 56.19M | - | 26.82M | -352.09M | -6.27 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Agios Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AGIO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 30.50 | 30.695 | 28.71 | 29.24 | 579,092 | -0.97 | -3.18% |
| 1 Month | 30.40 | 31.015 | 27.14 | 29.14 | 586,744 | -0.87 | -2.86% |
| 3 Months | 23.48 | 35.48 | 22.23 | 29.03 | 746,780 | 6.05 | 25.77% |
| 6 Months | 21.70 | 35.48 | 19.795 | 25.52 | 722,407 | 7.83 | 36.08% |
| 1 Year | 22.25 | 35.48 | 19.795 | 25.56 | 576,635 | 7.28 | 32.72% |
| 3 Years | 54.13 | 62.155 | 16.75 | 31.47 | 596,007 | -24.60 | -45.45% |
| 5 Years | 55.68 | 62.155 | 16.75 | 36.95 | 640,363 | -26.15 | -46.96% |
Agios Pharmaceuticals Description
| Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval. |
